| 000 | 00599nam a2200109Ia 4500 | ||
|---|---|---|---|
| 008 | 230718s9999 xx 000 0 und d | ||
| 100 | _aMarilyn K. Glassberg | ||
| 245 | 0 | _aCardiovascular Risks, Bleeding Risks, and Clinical Events from 3 Phase III Trials of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis | |
| 650 | _aComputer science, information & general works | ||
| 856 | _uhttps://new.zodml.org/sites/default/files/2023-07/cardiovascular_risks_bleeding_risks_and_clinical_events_from_3_phase_iii_trials_of_pirfenidone_in_patients_with_idiopathic_pulmonary_fibrosis.pdf | ||
| 942 | _cEBK | ||
| 999 |
_c19091 _d19091 |
||